Clinical aspects of antimicrobial resistance

Abinash Virk, James M. Steckelberg

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Soon after penicillin was introduced into clinical use, an enzyme (penicillinase) that inactivated it was discovered. Since then, the variety of antimicrobial agents has increased substantially, along with a parallel increase in resistant pathogenic microorganisms. Resistance is now recognized against all available antimicrobial agents. Factors influencing the emergence of resistance include indiscriminate use of antibiotics, prolonged hospitalizations, increasing numbers of immunocompromised patients, and medical progress resulting in increased use of invasive procedures and devices. This article provides an update on clinical aspects of a few commonly found resistant microorganisms relevant to day-to-day clinical practice. A discussion of all resistant organisms is beyond the scope of this report. Both viral and mycobacterial resistance have been addressed in previous articles in this symposium.

Original languageEnglish (US)
Pages (from-to)200-214
Number of pages15
JournalMayo Clinic Proceedings
Volume75
Issue number2
StatePublished - 2000

Fingerprint

Anti-Infective Agents
Penicillinase
Immunocompromised Host
Penicillins
Hospitalization
Anti-Bacterial Agents
Equipment and Supplies
Enzymes

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Virk, A., & Steckelberg, J. M. (2000). Clinical aspects of antimicrobial resistance. Mayo Clinic Proceedings, 75(2), 200-214.

Clinical aspects of antimicrobial resistance. / Virk, Abinash; Steckelberg, James M.

In: Mayo Clinic Proceedings, Vol. 75, No. 2, 2000, p. 200-214.

Research output: Contribution to journalArticle

Virk, A & Steckelberg, JM 2000, 'Clinical aspects of antimicrobial resistance', Mayo Clinic Proceedings, vol. 75, no. 2, pp. 200-214.
Virk A, Steckelberg JM. Clinical aspects of antimicrobial resistance. Mayo Clinic Proceedings. 2000;75(2):200-214.
Virk, Abinash ; Steckelberg, James M. / Clinical aspects of antimicrobial resistance. In: Mayo Clinic Proceedings. 2000 ; Vol. 75, No. 2. pp. 200-214.
@article{26de220798434ded89ebd1d3e794c353,
title = "Clinical aspects of antimicrobial resistance",
abstract = "Soon after penicillin was introduced into clinical use, an enzyme (penicillinase) that inactivated it was discovered. Since then, the variety of antimicrobial agents has increased substantially, along with a parallel increase in resistant pathogenic microorganisms. Resistance is now recognized against all available antimicrobial agents. Factors influencing the emergence of resistance include indiscriminate use of antibiotics, prolonged hospitalizations, increasing numbers of immunocompromised patients, and medical progress resulting in increased use of invasive procedures and devices. This article provides an update on clinical aspects of a few commonly found resistant microorganisms relevant to day-to-day clinical practice. A discussion of all resistant organisms is beyond the scope of this report. Both viral and mycobacterial resistance have been addressed in previous articles in this symposium.",
author = "Abinash Virk and Steckelberg, {James M.}",
year = "2000",
language = "English (US)",
volume = "75",
pages = "200--214",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "2",

}

TY - JOUR

T1 - Clinical aspects of antimicrobial resistance

AU - Virk, Abinash

AU - Steckelberg, James M.

PY - 2000

Y1 - 2000

N2 - Soon after penicillin was introduced into clinical use, an enzyme (penicillinase) that inactivated it was discovered. Since then, the variety of antimicrobial agents has increased substantially, along with a parallel increase in resistant pathogenic microorganisms. Resistance is now recognized against all available antimicrobial agents. Factors influencing the emergence of resistance include indiscriminate use of antibiotics, prolonged hospitalizations, increasing numbers of immunocompromised patients, and medical progress resulting in increased use of invasive procedures and devices. This article provides an update on clinical aspects of a few commonly found resistant microorganisms relevant to day-to-day clinical practice. A discussion of all resistant organisms is beyond the scope of this report. Both viral and mycobacterial resistance have been addressed in previous articles in this symposium.

AB - Soon after penicillin was introduced into clinical use, an enzyme (penicillinase) that inactivated it was discovered. Since then, the variety of antimicrobial agents has increased substantially, along with a parallel increase in resistant pathogenic microorganisms. Resistance is now recognized against all available antimicrobial agents. Factors influencing the emergence of resistance include indiscriminate use of antibiotics, prolonged hospitalizations, increasing numbers of immunocompromised patients, and medical progress resulting in increased use of invasive procedures and devices. This article provides an update on clinical aspects of a few commonly found resistant microorganisms relevant to day-to-day clinical practice. A discussion of all resistant organisms is beyond the scope of this report. Both viral and mycobacterial resistance have been addressed in previous articles in this symposium.

UR - http://www.scopus.com/inward/record.url?scp=0033953344&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033953344&partnerID=8YFLogxK

M3 - Article

C2 - 10683663

AN - SCOPUS:0033953344

VL - 75

SP - 200

EP - 214

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 2

ER -